Jinan Hongyuan Chemical Co.,Ltd

Jinan Hongyuan Chemical Co.,Ltd

86-13954187575

Jinan Hongyuan Chemical Co.,Ltd
홈페이지> 블로그> Sinopharm Hyundai's "universal antioxidant" lipoic acid API was approved in India and South Korea

Sinopharm Hyundai's "universal antioxidant" lipoic acid API was approved in India and South Korea

January 05, 2022
Beijing News (Reporter Zhang Zhaohui) On December 15th, Sinopharm Hyundai announced that its wholly-owned subsidiary Sinopharm Weiqida's lipoic acid APIs have obtained the API registration certificates of India and South Korea.

Lipoic acid is a powerful new antioxidant, also known as a universal antioxidant. It can support the activity of glucose in human cells, has a strong antioxidant effect, can remove free radicals in the body, and protect the health of the heart and other internal organs. The PDB database shows that in 2020, global sales of lipoic acid preparations will be USD 540.5 million. The main domestic manufacturers of lipoic acid APIs include Suzhou Fujilai Pharmaceutical Co., Ltd. and Jiangsu Tonghe Pharmaceutical Co., Ltd. etc.

Sinopharm Hyundai stated that the overseas registration certificate for lipoic acid this time indicates that the API product can be sold in the Indian and South Korean markets, and will have a positive impact on the further expansion of the international market.
문의하기

Author:

Ms. Yi

Phone/WhatsApp:

+8618888297294

인기 상품
You may also like
Related Categories

이 업체에게 이메일로 보내기

제목:
이메일:
메시지:

Your message must be betwwen 20-8000 characters

홈페이지

Product

Whatsapp

우리에 대해

문의

We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

송신